Home › Giant Cell Arteritis › New York › New York City
Giant Cell Arteritis clinical trials in New York City, NY
3 studies for Giant Cell Arteritis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Abatacept for the Treatment of Giant Cell Arteritis
RecruitingPhase 3
- Hospital for Special Surgery, New York
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
RecruitingPhase 2
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
- NYU Langone Health, New York
About Giant Cell Arteritis
Giant cell arteritis causes inflammation and narrowing of the arteries in the head. It often occurs with the disease polymyalgia rheumatica. Learn more.
More about Giant Cell Arteritis on MedlinePlus
Giant Cell Arteritis trials in other cities
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.